Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price
₹2,496.30
Market cap
₹1,03,108 Cr
Revenue (annual)
₹14,278 Cr
Net profit (annual)
₹1,913 Cr
P/E (TTM)
50.5×Sector 47.4×
Promoter holding
72.63%-0.03% QoQ
FII holding
9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:07 IST NSE
Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma announced the successful passing of a special resolution to appoint Mr. Anish Vanraj Bafna as a Non-Executive Independent Director. The Postal Ballot concluded with the required majority.

15:48 IST BSE
Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma Limited has issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Anish Vanraj Bafna as a Non-Executive Independent Director.

17:32 IST NSE
Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma held its 35th Annual General Meeting on August 4, 2026. The meeting covered routine business, including the adoption of financial statements and director re-appointments.

16:34 IST BSE
Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma has scheduled its 35th AGM for August 4, 2026, via video conferencing. The company also released its Annual Report for FY 2025-26.

11:54 IST NSE
Annual General Meeting

Mankind Pharma Annual General Meeting

Mankind Pharma Ltd will hold its 35th Annual General Meeting on August 4, 2026 via video conference. Notice and the annual report will be sent to members.